文献速递儿科与产科急症重症综合管理与镇静镇痛

新生儿临床试验中纳入的合格婴儿及未纳入原因:一项系统评价

Eligible Infants Included in Neonatal Clinical Trials and Reasons for Noninclusion: A Systematic Review.
PubMed 文献 · JAMA Netw Open · 2024-10-01
一句话结论新生儿临床试验中仅44.4%合格婴儿被纳入,父母拒绝参与(29.8%)和从未被接触(9.3%)是主因。

该系统评价检索Cochrane CENTRAL 2017至2022年发表的美国新生儿重症监护病房临床试验文章,纳入120篇(至少20名婴儿),其中91篇(75.8%)报告了合格婴儿数,合计26854名。汇总仅11924名合格婴儿(44.4%)被纳入报告结果。未纳入原因多数被归类为研究团队可改变或可能改变:父母拒绝参与8004名(29.8%)、从未被接触2507名(9.3%),研究后勤相关因素如未恰当收集已入组婴儿数据859/26854名(3.2%)、其他原因1907/26854名(7.1%)。不可改变原因如临床变化或死亡仅858/26854名(3.2%)。作者认为需改进合格婴儿流程记录,并了解父母拒绝及未被接触的原因以提高参与率。

要点

  • 91篇报告合格婴儿数的试验中,合计26854名合格婴儿仅11924名(44.4%)被纳入报告结果。
  • 父母拒绝参与是首位未纳入原因,涉及8004名婴儿(29.8%)。
  • 从未被接触是第二位未纳入原因,涉及2507名婴儿(9.3%)。
  • 研究后勤相关可改变原因包括未恰当收集已入组婴儿数据(859/26854,3.2%)和其他原因如失访或合格参与者未计入(1907/26854,7.1%)。
  • 不可改变原因如临床变化或死亡仅占858/26854名(3.2%)。

适用人群与场景

  • 美国新生儿重症监护病房中参与临床试验的婴儿,文章需描述至少20名人类婴儿的临床试验结果。
  • 纳入标准:全文同行评议文章、英文发表、2017至2022年添加到Cochrane CENTRAL。

研究设计与关键结果

  • 系统评价检索Cochrane CENTRAL,由2名独立研究者筛选,最终纳入120篇文章,其中91篇(75.8%)报告了合格婴儿数,合计26854名合格婴儿。
  • 汇总仅11924名合格婴儿(44.4%)被纳入报告结果。
  • 父母拒绝参与涉及8004名婴儿(29.8%),从未被接触涉及2507名婴儿(9.3%),为前两位未纳入原因。
  • 研究后勤相关可改变原因:未恰当收集已入组婴儿数据859/26854名(3.2%),其他原因如失访或合格参与者未计入1907/26854名(7.1%)。
  • 不可改变原因如临床变化或死亡涉及858/26854名(3.2%)。

证据类型、等级与局限

  • 证据类型:系统评价。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,该研究强调需改进新生儿临床试验中合格婴儿流程的记录,并可能为未来方案设计者提供招募预期参考。
  • 作者认为,提高对标准化报告的依从性可能明确哪些潜在参与者被遗漏,改善对研究结果普遍性的理解。
  • 作者认为,未来了解父母为何拒绝参与新生儿研究试验以及为何一些父母从未被接触,可能有助于提高总体参与率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Results of clinical trials can only represent included participants, and many neonatal trials fail due to insufficient participation. Infants not included in research may differ from those included in meaningful ways, biasing the sample and limiting the generalizability of findings.

OBJECTIVE: To describe the proportion of eligible infants included in neonatal clinical trials and the reasons for noninclusion.

EVIDENCE REVIEW: A systematic search of Cochrane CENTRAL was performed by retrieving articles meeting the following inclusion criteria: full-length, peer-reviewed articles describing clinical trial results in at least 20 human infants from US neonatal intensive care units, published in English, and added to Cochrane CENTRAL between 2017 and 2022. Retrieved articles were screened for inclusion by 2 independent researchers.

FINDINGS: In total 120 articles met inclusion criteria and 91 of these (75.8%) reported the number of infants eligible for participation, which totaled 26 854 in aggregate. Drawing from these, an aggregate of 11 924 eligible infants (44.4%) were included in reported results. Among all eligible infants, most reasons for noninclusion in results were classified as modifiable or potentially modifiable by the research team. Parents declining to participate (8004 infants [29.8%]) or never being approached (2507 infants [9.3%]) were the 2 predominant reasons for noninclusion. Other modifiable reasons included factors related to study logistics, such as failure to appropriately collect data on enrolled infants (859 of 26 854 infants [3.2%]) and other reasons (1907 of 26 854 infants [7.1%]), such as loss to follow-up or eligible participants that were unaccounted for. Nonmodifiable reasons, including clinical change or death, accounted for a small proportion of eligible infants who were not included (858 of 26 854 infants [3.2%]).

CONCLUSIONS AND RELEVANCE: This systematic review of reporting on eligible infants included and not included in neonatal clinical trials highlights the need for improved documentation on the flow of eligible infants through neonatal clinical trials and may also inform recruitment expectations for trialists designing future protocols. Improved adherence to standardized reporting may clarify which potential participants are being missed, improving understanding of the generalizability of research findings. Furthermore, these findings suggest that future work to understand why parents decline to participate in neonatal research trials and why some are never approached about research may help increase overall participation.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Shaikh H, Lyle ANJ, Oslin E, et al. Eligible Infants Included in Neonatal Clinical Trials and Reasons for Noninclusion: A Systematic Review. JAMA Netw Open. 2024. PMID: 39453652. doi:10.1001/jamanetworkopen.2024.41372

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。